15 3月 2022 by admin in UncategorizedComments Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
15 3月 2022 by admin in UncategorizedComments Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress
10 3月 2022 by admin in UncategorizedComments Design Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
04 3月 2022 by admin in UncategorizedComments Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 3月 2022 by admin in UncategorizedComments NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
28 2月 2022 by admin in UncategorizedComments Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTACTM Molecule for Friedreich Ataxia
16 2月 2022 by admin in UncategorizedComments Walking Fish Therapeutics Closes $73 Million Series A Financing
08 2月 2022 by admin in UncategorizedComments Arcellx Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
02 2月 2022 by admin in UncategorizedComments Syros Receives FDA Orphan Drug Designation for Tamibarotene for the Treatment of MDS
01 2月 2022 by admin in UncategorizedComments Design Therapeutics Appoints Drug Development Expert, Jae Kim, M.D., as Chief Medical Officer
17 1月 2022 by admin in UncategorizedComments (English) Eluminex Biosciences Successfully Completes Its First Pre-IND Meeting with the United States Food and Drug Administration for a Multivalent Fc Fusion Protein (EB-101) for the Treatment of Neovascular Age-related Macular Degeneration
10 1月 2022 by admin in UncategorizedComments Syros Announces Clinical Updates and 2022 Goals to Support its Advancement to a Fully Integrated Biopharmaceutical Company
10 1月 2022 by admin in UncategorizedComments BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
12 12月 2021 by admin in UncategorizedComments NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual Meeting
10 12月 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
09 12月 2021 by admin in UncategorizedComments Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
26 11月 2021 by admin in UncategorizedComments Crescendo Biologics Wins “Best Established Biotech Company” at the 2021 OBN Awards
21 11月 2021 by admin in UncategorizedComments Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
18 11月 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 11月 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
18 11月 2021 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
16 11月 2021 by admin in UncategorizedComments KIRA PHARMACEUTICALS APPOINTS TERI LOXAM AS CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
12 11月 2021 by admin in UncategorizedComments Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
10 11月 2021 by admin in UncategorizedComments Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 11月 2021 by admin in UncategorizedComments Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
09 11月 2021 by admin in UncategorizedComments Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
05 11月 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
01 11月 2021 by admin in UncategorizedComments Laronde Expands Board of Directors with Leading Pharmaceutical Executives
20 10月 2021 by admin in UncategorizedComments Crescendo Biologics announces prestigious new collaboration with The Institute of Cancer Research, London
19 10月 2021 by admin in UncategorizedComments NextCure Announces Three New Members of its Scientific Advisory Board
13 10月 2021 by admin in UncategorizedComments Syros Reports Inducement Grant to Chief Financial Officer under Nasdaq Listing Rule 5635(c)(4)
13 10月 2021 by admin in UncategorizedComments Eluminex Biosciences Announces the Grand Opening of New Global Headquarters and Research and Development Center in Suzhou
